President Donald Trump hinted at the possibility of the United States rejoining the World Health Organization (WHO), days after initiating the country’s withdrawal. Speaking at a rally in Las Vegas, Trump stated, “Maybe we would consider doing it again... They would have to clean it up.” The U.S. is set to leave the WHO on January 22, 2026, following Trump’s decision after being sworn in for a second term.
Trump criticized the WHO’s handling of the COVID-19 pandemic and other global health crises, expressing frustration that the U.S. contributes significantly more funding than China despite its smaller population. The U.S. currently accounts for approximately 18% of the WHO’s $6.8 billion budget for 2024-2025, making it the organization’s largest financial supporter.
In his speech, Trump also discussed expanding economic ties with Saudi Arabia. He shared that Crown Prince Mohammed bin Salman recently pledged $600 billion in investments and trade over the next four years. Trump said he aims to increase this figure to $1 trillion to boost the U.S. economy.
Trump’s remarks highlight his focus on prioritizing U.S. interests in international organizations and partnerships. Whether the U.S. returns to the WHO will likely depend on reforms addressing Trump’s concerns over funding disparities and operational efficiency.
These developments come as Trump seeks to reshape global alliances while emphasizing stronger investment ties with key partners like Saudi Arabia.


Australia Progresses AUKUS Review as U.S. Affirms Strong Support
U.S. Repatriation Flight Carrying 266 Venezuelan Migrants Lands in Caracas
Senators Warn Trump Against Unauthorized Venezuela Strike, Vow War Powers Push
Pentagon Probe Finds Hegseth’s Use of Signal Risked Exposing Sensitive Yemen Strike Details
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
U.S. Reveals 2026 Medicare Star Ratings: Aetna, UnitedHealth Lead in Quality Scores
Pfizer Secures $10 Billion Deal for Obesity Drug Developer Metsera, Outbids Novo Nordisk
Eli Lilly’s Weight-Loss Pill Nears Fast-Track FDA Approval as Profits Surge on Global Demand
New Orleans Immigration Crackdown Sparks Fear as Federal Arrests Intensify
Canada Loses Measles-Free Status After Nearly 30 Years Amid Declining Vaccination Rates
Novo Nordisk Appoints Greg Miley as Global Head of Corporate Affairs Amid U.S. Pricing Pressure
Putin Concludes High-Level Talks With Trump Envoy on Ending Ukraine Conflict
Trump Administration Halts Immigration, Green Card, and Citizenship Processing for 19 Countries
FDA Pilot Program Eases Rules for Nicotine Pouch Makers
Trump Administration Tightens H-1B Visa Vetting With New Focus on Free Speech and Censorship
Trump Claims He Will Void Biden Documents Signed with Autopen
Pfizer Sues Novo Nordisk Over Alleged Tactics to Block Obesity Drug Competition 



